Autopsy report · NCT01172444

Clinical Trial With Mesalamine 1g Suppositories

“Enrollment difficulties”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 2 years 6 months before it stopped.
• 158 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Sandoz

Sponsor type

Industry

Conditions

Proctitis

Interventions

Mesalamine; Canasa; Placebo

Participants

158

Sites

38

Countries

India

Trials that died the same way

• AVAD: Asthma With Small Airways Dysfunction
  “difficulties of enrollment” (98% match in meaning)
• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (97% match in meaning)
• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
  “difficulty in enrollment” (95% match in meaning)
• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (93% match in meaning)
• Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
  “Difficult enrollment” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.